Clinical trial

Israeli 10 mL Bronchoscopic Lung Volume Reduction (BLVR) Phase 1/2 Emphysema Study - Initial Formulation

NCT00205907

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2005-01-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2005-01-01Date precision: month

Registry last updated2008-03-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Emphysemaunresolved

Interventions

BLVR HydrogelBIOLOGICAL

Sponsors & collaborators

Aeris Therapeuticslead sponsor

Mapped research locations

Ramat GanIsrael1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00205907 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.